Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; TSX: $APH.TO,
TSXV: $ALEF.V, CSE: $MTEC.C, CSE:
$CROP.C, TSXV: $GENE.V
July 9th Potcast sponsored
by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) a #Cannabis company with
a new disruptive drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –July 9, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the July 9 podcast: http://www.investorideas.com/Audio/Podcasts/2018/070918-StocksToWatch.mp3
Read this in full at http://www.investorideas.com/news/2018/cannabis/07094Potcasts-TSX-APH-TSXV-ALEF-CSE-MTEC-CROP-GENE.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast ; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news
announcements from Aphria Inc. (TSX: APH and US OTC: APHQF) , Aleafia
Health Inc ( TSX-Venture : ALEF and OTCQX: ALEAF) , Cannvas MedTech Inc. (CSE: MTEC) , CROP Infrastructure Corp. (CSE:
CROP) and INVICTUS
MD STRATEGIES CORP. (TSX-Venture: GENE and OTC: IVITF).
Aphria Inc.
announced that they will release their fourth quarter results for 2018 on
August 1, 2018.
Financial
results are expected to be released at approximately 7:00am ET, through SEDAR
and on Aphria's website at www.aphria.ca/investors. A conference call will be scheduled for
9:00am ET and will feature a presentation by Aphria executives followed by a
question and answer period with analysts. Details with respect to the analyst
conference call with be released closer to August 1st.
Aleafia
Health Inc., one of Canada's leading, vertically integrated medical
cannabis companies with a unique patient-focused, healthcare solution, provided
an update further to the press release dated July 6, 2018, on the acquisition
of the 160,000 square foot cultivation facility located in Grimsby, Ontario.
Aleafia
reported that the zoning variance required by Aleafia for the Grimsby facility
was accepted and passed late Friday afternoon. As previously disclosed, the
Company expects to close on the transaction in late July, after completion of
the 20 day appeal process.
Cannvas MedTech Inc, a leading
business technology company within the cannabis space, announce that its first
cannabis-centric service offering to the public will be Cannvas.me, with an anticipated launch in Q3 of 2018. An
innovative approach at placing cannabis education at the forefront of this
service offering, Cannvas.me is a scalable and comprehensive solution for the
global cannabis community offering interactive tools and physician-backed
content to all audiences who wish to learn about healthcare through
cannabis.
"Education
without the outside influence is our primary mission with Cannvas.me,"
said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. "Cannvas.me places the needs of its
users first, in their pursuit of alternative healthcare, by educating them on
treatments and support of a healthy and responsible lifestyle through the use
of cannabis. Being independent and not financially sponsored by the licensed
producer community, or other entities, helps ensure information is produced and
maintained in an unbiased fashion, free from outside influence."
CROP Infrastructure Corp. announced
that it has completed the required security upgrades on the ‘Humboldt County
Property’ in California and its tenant operator has planted 20,000 square feet
of recreational cannabis with Green Crack, Birthday Cake, and Green Scout
Cookie strains.
The Humboldt
County Property consists of an operational 10,000 square foot medicinal
cannabis greenhouse facility and has now obtained and planted an additional
20,000 square feet of recreational licensed canopy.
The tenant
had received final approval for the additional 20,000 square feet of
recreationally licensed canopy space subject to security upgrades. The
approval was given after CalCannabis, a division of the California Department
of Food and Agriculture (CDFA), had inspected the Humboldt California Campus.
CROP further
was informed by the tenant operator its first crop will be harvested by the end
of August. The 10,000 square feet of canopy is divided into five separate
greenhouses, expecting to yield approximately 150 lbs. per greenhouse.
According to
a report from BDS Analytics, sales of cannabis in California are expected to hit
$3.7 Billion in 2018 alone with that number expected to grow to $5.1 Billion in
2019 as more dispensaries come online.
INVICTUS MD STRATEGIES CORP. announced today the purchase of an additional acre of neighboring land
adjacent to AB Laboratories Inc. property, dedicated to future expansion
opportunities at the facility. The acquisition represents significant progress
in AB Labs' growth strategy which involves building a strong production profile
in state-of-the-art cultivation spaces.
Construction
of the Phase 2 expansion at AB Labs remains on-schedule. The Phase 2 facility
will add 40,000 square feet of operating space, while increasing total
cultivation capacity to 56,000 square feet. Currently, AB Labs' 16,000 square
foot Phase 1 facility is operating at full capacity, having completed its
second transfer of 63 kg of dried cannabis to Canopy Growth Corporation's (TSX:
WEED) Tweed's elite CraftGrow line.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration
Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info
http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment